# Treatment Outcomes for Temporomandibular Disorders (TMD) Via the Clayton Intra-aural Device (CID) Clinical Trial

> **NCT00815776** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ascentia Health, Inc.** · enrollment: 152 (actual)

## Conditions studied

- Temporomandibular Disorders

## Interventions

- **DEVICE:** Clayton Intra-aural Device (CID)
- **DEVICE:** Mouth Splint
- **OTHER:** Exercise Group

## Key facts

- **NCT ID:** NCT00815776
- **Lead sponsor:** Ascentia Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2010-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00815776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00815776, "Treatment Outcomes for Temporomandibular Disorders (TMD) Via the Clayton Intra-aural Device (CID) Clinical Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00815776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*